Retatrutide often called Reta in online communities is the next-generation weight loss peptide currently being studied by Eli Lilly
Lack of definitive outcomes: Many studies focus on surrogate biomarkers (GSH/GSSG, oxidative stress markers) rather than clinically meaningful endpoints
[PubMed: 21824127] [CrossRef] 38
Arroyave-Ospina JC, Wu Z, Geng Y, Moshage H (2021) Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: mplications for prevention and therapy
In studies combining NNMTi with other weightloss drugs, coadministration with GLP1 receptor agonists significantly enhances weightloss efficacy while reducing side effects such as nausea and vomiting commonly associated with GLP1 agonists
Currently, there is some research suggesting that the peptide can improve sexual function and erections in males